Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |